Voyageur Pharmaceuticals Ltd. (VM.V)
Voyageur Pharmaceuticals Ltd. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Calgary, AB, CA. The stock last traded at $0.17, up 3.13% on the session, giving a market capitalisation of $29.6M. Its beta of 0.29 implies it has historically moved less than the broad market.
Voyageur Pharmaceuticals Ltd. specializes in the creation of mineral-based active pharmaceutical ingredients (APIs). The company aims to produce radiocontrast agents utilizing barium and iodine, along with pharmaceutical products derived from bromine. It possesses complete ownership of three barium sulfate deposits in British Columbia, Canada, two of which are of a quality appropriate for the pharmaceutical barite sector. Furthermore, Voyageur holds stakes in a valuable brine project in Utah, United States, known for its high concentrations of iodine, lithium, and bromine. The company transitioned from its previous name, Voyageur Minerals Ltd., to Voyageur Pharmaceuticals Ltd. in December 2019. Its corporate headquarters are located in Calgary, Canada.
Voyageur Pharmaceuticals Ltd. is most often compared with the following Healthcare names: